Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Clinical trial NCT04735367 · COMPLETED
Trial details
- NCT number
- NCT04735367
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-03
- Primary completion
- 2023-09-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.